GUALTIERI, FULVIO

GUALTIERI, FULVIO  

Scienze farmaceutiche (attivo dal 01/08/1980 al 31/12/2012)  

Mostra records
Risultati 1 - 20 di 183 (tempo di esecuzione: 0.066 secondi).
Titolo Data di pubblicazione Autore(i) File
"Synthesis and binding properties of photoactivable Biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein" 1999 E. TEODORI; D. ETTORI; A. GARNIER-SUILLEROT; F. GUALTIERI; D. MANETTI; M.N. ROMANELLI; S. SCAPECCHI
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 2001 Silvia Dei; Elisabetta Teodori; Cristina Bellucci; Fulvio Gualtieri; Luca Guandalini; Rosanna Matucci; Serena Scapecchi; Katia Varani; Marta Ferraroni
1,2 BENZISOXAZOLES 1999 F. GUALTIERI; M. GIANNELLA
1,3-oxathiolane muscarinic ligands modified at the cationic head. 1994 Teodori E; Dei S; Romanelli M; Scapecchi S; Gualtieri F; Angeli P; Marucci G; Matucci R.
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 2000 D. Manetti; C. Ghelardini; A. Bartolini; C. Bellucci; S. Dei; N. Galeotti; F. Gualtieri; M.N. Romanelli; S Scapecchi; E. Teodori
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 2000 Dina Manetti; Carla Ghelardini; Alessandro Bartolini; Cristina Bellucci; Silvia Dei; Nicoletta Galeotti; Fulvio Gualtieri; Maria Novella Romanelli; Serena Scapecchi; Elisabetta Teodori
13C NMR SPECTRA OF 1,3-OXATHIOLANE, 1,3-OXATHIOLANE-3-OXIDE AND 1,3-OXATHIOLANE-3,3-DIOXIDE DERIVATIVES 1986 E. TEODORI; F. MELANI; F. GUALTIERI
2-PYRROLIDINONE MOIETY IS NOT CRITICAL FOR THE COGNITION ENHANCING ACTIVITY OF PIRACETAM-LIKE DRUGS 2003 S. SCAPECCHI; C. MARTELLI; C. GHELARDINI; L. GUANDALINI; E. MARTINI; F. GUALTIERI
25 Years later: latest news from the receptors 2004 F. GUALTIERI
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 1997 C. GHELARDINI; N. GALEOTTI; F. GUALTIERI; S. SCAPECCHI; A. BARTOLINI
4-(2-Pyrrolidinyl)-1,3-dioxolane derivatives as ligands for muscarinic and nicotinic receptors 1999 E. Teodori; S. Dei; F. Gualtieri; D. Manetti; M.N.Romanelli; S.Scapecchi
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 2003 D. MANETTI; E. MARTINI; C. GHELARDINI; S. DEI; N. GALEOTTI; L. GUANDALINI; M. ROMANELLI; S. SCAPECCHI; E. TEODORI; A. BARTOLINI; F. GUALTIERI
A DIRECT METALLATION APPROACH TO 2-ALKYLTHIO-2,2-DIARYL SUBSTITUTED ACETIC ACIDS 1996 F. GUALTIERI; A. MORDINI; S. PECCHI; S. SCAPECCHI
A recombinant transductor-effector system: in vitro study of G inhibitor protein (G-alfa-i1)direct activators 2006 L. DI CESARE MANNELLI; A. PACINI; A. TOSCANO; C. GHELARDINI; D. MANETTI; F. GUALTIERI; T. PATEL; A. BARTOLINI
A SEARCH FOR CALCIUM CHANNELS ACTIVATORS IN THE VERAPAMIL SERIES 1989 M. ROMANELLI; F. GUALTIERI; R. MANNHOLD; A. CHIARINI
A short synthesis of rigid 2-alkylthio-2,2-diaryl substituted acetic acids 1998 F. GUALTIERI; A. MORDINI; S. PECCHI; S. SCAPECCHI
Affinity and efficacy correlate with chemical structure more than potency does in a series of pentatomic cyclic muscarinic agonists 1985 P. ANGELI; L. BRASILI; M. GIANNELLA; F. GUALTIERI; M. PIGINI
AFFINITY PROFILES AT FIVE CLONED HUMAN MUSCARINIC RECEPTORS (M1-M5) OF A NEW SERIES OF ANTIMUSCARINIC DRUGS 1993 P. ANGELI; F. GUALTIERI; R. MAGGIO; F. PAPARELLI; S. SCAPECCHI;
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 2000 C. GHELARDINI; N. GALEOTTI; L. DI CESARE MANNELLI; S. DEI; F. GUALTIERI; A. BARTOLINI
Alpha-tropanyl esters that increase central ACh release: enantioselectivity studies support a double mechanism of action. 1995 F. GUALTIERI; A. BARTOLINI; C. BERTUCCI; S. DEI; C. GHELARDINI; M.G. GIOVANNINI; A. GIOTTI; G. PEPEU; M.N. ROMANELLI; S. SCAPECCHI; E. TEODORI.